Maeve O’Huallachain is a Principal Scientist in Discovery focused on target identification and validation. Some of her projects include optimizing tissue dissociation protocols and developing multimodal single-cell analysis workflows. Before joining Cartography, she was a Scientific Manager in the Cellular and Tissue Genomics Department at Genentech. She holds a PhD in Molecular, Cellular, and Developmental Biology from Yale University. In her free time, she enjoys cycling, playing boardgames with her husband, and building Lego towers with her two sons.
Recent Posts
- Cartography Biosciences and Pfizer to Collaborate on the Discovery of Tumor-Selective Antigens
- Cartography Receives FDA Investigational New Drug (IND) Approval and Fast Track Designation for Lead Program CBI-1214 for Colorectal Cancer
- Cartography Secures $67 Million Series B Financing to Advance Differentiated Oncology Pipeline of Antibody-Based Therapies into the Clinic
- Cartography Names Dirk Nagorsen, M.D., as Chief Medical Officer in Expansion of Its Clinical Team
- Cartography Announces Appointment of Troy Wilson, Ph.D., J.D., to its Board of Directors
Recent Comments
No comments to show.